Fragment-based inhibitor design for SARS-CoV2 main protease

COVID-19 disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2) has resulted in tremendous loss of lives across the world and is continuing to do so. Extensive work is under progress to develop inhibitors which can prevent the disease by arresting the virus in its life cycle....

Descripción completa

Detalles Bibliográficos
Autores principales: Andola, Priyanka, Pagag, Jishu, Laxman, Durgam, Guruprasad, Lalitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251026/
https://www.ncbi.nlm.nih.gov/pubmed/35811782
http://dx.doi.org/10.1007/s11224-022-01995-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251026/
https://www.ncbi.nlm.nih.gov/pubmed/35811782
http://dx.doi.org/10.1007/s11224-022-01995-z

Ejemplares similares